glp-1 semaglutide weight loss treatments kentucky GLP 1 For Can Weight-Loss Medications Containing Semaglutide
Description
Short-acting GLP-1 RAs, exenatide and lixisenatide, are associated with a transient (112 h) mean placebo- and baseline-adjusted 24-h HR increase of 13 beats per minute (bpm)
Does this data make GLP-1 coverage for weight loss more attractive
While some investors fear that the widespread use of GLP-1 drugs could diminish the demand for devices related to obesity and its comorbidities, others see an opportunity for synergistic growth
